A decade of national health data has quietly complicated one of medicine's most celebrated recent stories. GLP-1 medications like Ozempic demonstrably improve the bodies of diabetic patients — lowering blood sugar, reducing weight, protecting the heart — yet researchers at the University of Chicago found little evidence that these gains ripple outward into the broader landscape of a person's life. The study, spanning 2012 to 2023, raises a quietly profound question: when we heal the body, do we also heal the life it inhabits?